Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Edivoxetine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVE Three studies examined whether edivoxetine (a highly selective norepinephrine reuptake inhibitor) had efficacy as… Expand
Highly Cited
2015
Highly Cited
2015
In this study we demonstrate that molecular fragments, which can be readily coupled via a simple, in situ RO-C═OR bond-forming… Expand
  • table 2
2015
2015
Inhibition of norepinephrine (NE) reuptake into noradrenergic nerves is a common therapeutic target in the central nervous system… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
2015
2015
Norepinephrine, a neurotransmitter in the autonomic sympathetic nervous system, is deaminated by monoamine oxidase to 3,4… Expand
2014
2014
BACKGROUND This phase 2 study examined the efficacy and tolerability of edivoxetine, a highly selective norepinephrine reuptake… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2014
2014
OBJECTIVE The purpose of this study was to assess the efficacy and safety of edivoxetine (LY2216684), a selective norepinephrine… Expand
2014
2014
The catechol-O-methyltransferase (COMT) enzyme is responsible for degradation of catecholamines, such as dopamine (DA) and… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
Review
2013
Review
2013
There are several investigational drugs in development for the treatment of depression. Some of the novel antidepressants in… Expand
2013
2013
OBJECTIVE The purpose of this study was to assess the clinical outcomes from an open label study of edivoxetine, a selective… Expand
2012
2012
OBJECTIVE Edivoxetine (LY2216684) is a selective and potent norepinephrine reuptake inhibitor (NERI). The pharmacokinetics (PK… Expand